Prosecution Insights
Last updated: April 19, 2026
Application No. 17/318,330

CONTROLLER FOR AN ELECTRICAL DRIVE UNIT OF AN OPHTHALMOSURGICAL HANDPIECE AND METHOD FOR OPERATING SAME, OPHTHALMOSURGICAL APPARATUS AND SYSTEM

Non-Final OA §102§103§112
Filed
May 12, 2021
Examiner
IGBOKO, CHIMA U
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Carl Zeiss Meditec AG
OA Round
5 (Non-Final)
78%
Grant Probability
Favorable
5-6
OA Rounds
3y 6m
To Grant
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allow Rate
319 granted / 408 resolved
+8.2% vs TC avg
Strong +41% interview lift
Without
With
+40.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
44 currently pending
Career history
452
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
42.6%
+2.6% vs TC avg
§102
29.5%
-10.5% vs TC avg
§112
21.8%
-18.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 408 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 01/20/26 has been entered. Response to Amendment The Amendment filed 02/24/26 has been entered. Claims 1-2 and 6-7 have been amended, new claim 12 has been entered, and claims 9-10 remain withdrawn. Claims 1-8 and 11-12 are addressed in the following office action Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-8 and 12 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Downey et al. (US 2017/0143369). Regarding claim 1, an invention relating to an ultrasonic handpiece, Downey discloses (Figs. 2-3 & 7) (Fig. 25) a controller (240) for an electrical drive unit (32) which drives a treatment needle (142) of an ophthalmosurgical handpiece for processing an eye lens (Par. 0027) [Note, the ophthalmosurgical handpiece and associated structures are not interpreted as part of the claimed invention because the structures have not been positively recited], comprising: a generator unit (242 & 244; Par. 0049) for providing an electrical control variable [i.e. drive signal] for the electrical drive unit (Par. 0027), wherein the generator unit is configured to: provide the electrical control variable with a control oscillation [i.e. components] (Par. 0060-0061), wherein the control oscillation has a first oscillation component at a first control frequency (Par. 0060-0061, 0087, 0089), wherein a first electrical amplitude of the first oscillation component is adjusted based on a first ratio of a mechanical deflection amplitude of the treatment needle to the electrical control variable at the first control frequency [i.e. a ratio between current applied to the at least one driver and the equivalent of current applied to the mechanical components of the handpiece], wherein the mechanical deflection amplitude of the treatment needle is a mechanical movement of the treatment needle [i.e. vibration (the mechanical deflection amplitude) of the mechanical components represented as component (voltage, current, frequency, etc.)] (Abstract; Claim 1 from Downey & Par. 0055-0056, 0063-0064, 0069-0071, 0088-0092, 0095-0096); and provide the control oscillation of the electrical control variable with at least one further oscillation component [i.e. the second of the two AC signals] at a further control frequency, different than any other control frequency, wherein a further electrical amplitude of the further oscillation component is adjusted based on a further ratio of the mechanical deflection amplitude of the treatment needle to the electrical control variable at the respective further control frequency (Abstract; Claim 1 from Downey & Par. 0055-0056, 0061, 0063-0064, 0069-0071, 0088-0092, 0095-0096). Regarding claim 2, Downey discloses the controller as claimed in claim 1. Downey discloses (Figs. 3-4) further configured to: access, from a storage unit (56 & 184), individual values for the respective ratios of the mechanical deflection amplitude of the treatment needle to the electrical control variable are based on the respective control frequency (Par. 0032-0035 & 0045-0047). Regarding claim 3, Downey discloses the controller as claimed in claim 1. Downey further discloses wherein the generator unit is furthermore configured to superpose at least a plurality of oscillation components at mutually different control frequencies in order to provide a predefinable oscillation waveform of the electrical control variable (Par. 0061). Regarding claim 4, Downey discloses the controller as claimed in claim 3. Downey further discloses wherein the generator unit is furthermore configured to carry out the superposing at least partly as modulation (Par. 0061). Regarding claim 5, Downey discloses the controller as claimed in claim 1. Downey further discloses wherein the generator unit provides the electrical control variable in such a way that a first time period assignable to an outgoing movement of the treatment needle is shorter than a second time period assignable to a return movement of the treatment needle (Fig. 8; Par. 0061; 0085; 0113). Regarding claim 6, Downey discloses the controller as claimed in claim 1. Downey further discloses (Fig. 7) configured to: receive, from a sensor unit (262 & 266) for detecting a movement of the treatment needle, a sensor signal indicating the detected movement of the treatment needle, determine, at the generator unit, the respective control frequencies of the sensor signal; determine the ratios of the mechanical deflection amplitude of the treatment needle to the electrical control variable at each of the respective control frequencies; and update the electrical control variable based on the ratios of the mechanical deflection amplitude to the electrical control variable (Claim 1 of Downey; Par. 0051 & 0086-0087). Regarding claim 7, an invention relating to an ultrasonic handpiece, Downey discloses (Figs. 2-3 & 7) an ophthalmosurgical apparatus (30) comprising:- an ophthalmosurgical handpiece (32 & 142) for processing an eye lens (Par. 0027), said handpiece being drivable by means of a drive unit (Par. 0028) [Note, drive unit is not interpreted as part of the claimed invention because the structures have not been positively recited]; and - a controller (240) connectable to the ophthalmosurgical handpiece at least during operation as intended (Par. 0074), wherein the controller comprises: a generator unit (242 & 244; Par. 0049) for providing an electrical control variable [i.e. drive signal] for the electrical drive unit (Par. 0027), wherein the generator unit is configured to: provide the electrical control variable with a control oscillation [i.e. components] (Par. 0060-0061), wherein the control oscillation has a first oscillation component at a first control frequency (Par. 0060-0061, 0087, 0089), wherein a first electrical amplitude of the first oscillation component is adjusted based on a first ratio of a mechanical deflection amplitude of the treatment needle to the electrical control variable at the first control frequency [i.e. a ratio between current applied to the at least one driver and the equivalent of current applied to the mechanical components of the handpiece], wherein the mechanical deflection amplitude of the treatment needle is a mechanical movement of the treatment needle [i.e. vibration (the mechanical deflection amplitude) of the mechanical components represented as component (voltage, current, frequency, etc.)] (Abstract; Claim 1 from Downey & Par. 0055-0056, 0063-0064, 0069-0071, 0088-0092, 0095-0096); and provide the control oscillation of the electrical control variable with at least one further oscillation component [i.e. the second of the two AC signals] at a further control frequency, different than any other control frequency, wherein a further electrical amplitude of the further oscillation component is adjusted based on a further ratio of the mechanical deflection amplitude of the treatment needle to the electrical control variable at the respective further control frequency (Abstract; Claim 1 from Downey & Par. 0055-0056, 0061, 0063-0064, 0069-0071, 0088-0092, 0095-0096). Regarding claim 8, Downey discloses an ophthalmosurgical system for processing an eye lens, at least comprising: - an irrigation apparatus, - an aspiration apparatus, and- an ophthalmosurgical apparatus, wherein the ophthalmosurgical apparatus is configured as claimed in claim 7 (Par. 0044). Regarding claim 12, Downey discloses the controller as claimed in claim 1. Downey further discloses wherein the electrical control variable comprises at least one of an electric voltage or an electric current (Par. 0033). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 11 is rejected under 35 U.S.C. 103 as being unpatentable over Downey et al. (US 2017/0143369) as applied to claim 6 above, and further in view of Zacharias (US 2007/0129732). Regarding claim 11, Downey discloses the controller as claimed in claim 6. However, Downey further discloses wherein the sensor unit utilizes a current measuring circuit to determine the detected movement of the treatment needle (Par. 0051-0053 & 0087). However, Zacharias fails to disclose wherein the sensor unit utilizes optical detection methods to determine the detected movement of the treatment needle. In the analogous art of surgical tool that vibrates, Zacharias teaches the position sensor element 80 can be constituted by one or more strain gauges, Eddy current sensors, capacitive position sensors, optical position sensors, LVDTs or any other position sensor elements suitable to detect in real time the axial position and displacement information of the oscillating spring-mass mechanism and of the driving piezoelectric actuator (Par. 0050). Showing that current measuring circuits and optical position sensors are equivalent structures known in the art. Therefore, because these two means of sensing position were art-recognized equivalents at the time the invention was made, one of ordinary skill in the art would have found it obvious to substitute the current measuring circuit for the optical detection method. Substitution of one known element for another element providing the same function to yield predictable results would have been obvious to one of ordinary skill in the art at the time of the invention. Response to Arguments Applicant’s arguments, see pages 6-9, filed 02/24/26, with respect to the rejections of claims 1-8 under 35 USC § 112 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new grounds of rejection is made in view of newly cited prior art. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Examiner Chima Igboko whose telephone number is (571)272-8422. The examiner can normally be reached on Monday-Friday 9:00am-6:00pm. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Jackie Ho, at (571) 272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /C.U.I/ Examiner, Art Unit 3771 /ASHLEY L FISHBACK/Primary Examiner, Art Unit 3771 March 24, 2026
Read full office action

Prosecution Timeline

May 12, 2021
Application Filed
Jun 11, 2024
Non-Final Rejection — §102, §103, §112
Sep 17, 2024
Response Filed
Dec 02, 2024
Final Rejection — §102, §103, §112
Jan 03, 2025
Applicant Interview (Telephonic)
Jan 03, 2025
Examiner Interview Summary
Feb 21, 2025
Applicant Interview (Telephonic)
Feb 21, 2025
Examiner Interview Summary
Mar 12, 2025
Request for Continued Examination
Mar 13, 2025
Response after Non-Final Action
Mar 18, 2025
Non-Final Rejection — §102, §103, §112
Jul 22, 2025
Applicant Interview (Telephonic)
Jul 22, 2025
Examiner Interview Summary
Jul 28, 2025
Response Filed
Oct 09, 2025
Final Rejection — §102, §103, §112
Jan 20, 2026
Request for Continued Examination
Feb 17, 2026
Response after Non-Final Action
Feb 24, 2026
Response Filed
Mar 16, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599499
DEVICES AND METHODS FOR CREATING A CAPSULORHEXIS
2y 5m to grant Granted Apr 14, 2026
Patent 12569362
DELIVERY DEVICE AND METHOD OF DELIVERY
2y 5m to grant Granted Mar 10, 2026
Patent 12569332
IOL INJECTOR WITH AUTOMATIC DRIVER OR ASSISTED MANUAL DRIVE FORCE
2y 5m to grant Granted Mar 10, 2026
Patent 12569327
INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION AND EMBOLIC PROTECTION DEVICE
2y 5m to grant Granted Mar 10, 2026
Patent 12558096
FULL EVERSION ANASTOMOSIS JUNCTURE FORMATION AND SUTURING
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+40.8%)
3y 6m
Median Time to Grant
High
PTA Risk
Based on 408 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month